Ester Baiget never planned to be CEO. Then a future bioscience giant came calling
AI Summary
Ester Baiget's unexpected transition from Dow to helming Novozymes after 25 years underscores a shift driven by a desire to impact society through biosolutions rather than sheer ambition. Her leadership philosophy, rooted in family values and a commitment to long-term purpose, highlights the courage needed to guide mergers like the one with Chr. Hansen. Baiget's story emphasizes the importance of respect and vision in steering a company towards sustainable growth and innovation in the bioscience sector.
Original Source
Read the full article at Cnbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.